期刊文献+

MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2 被引量:15

MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2
下载PDF
导出
摘要 AIM:To investigate the function of microRNA-143(miR-143)in gastric cancer and explore the target genes of miR-143.METHODS:A quantitative real-time reverse transcription-polymerase chain reaction(RT-PCR)analysis was performed to evaluate miR-143 expression in gastric cancer cell lines.After transfecting gastric cancer cells with miR-143-5p and miR-143-3p precursors,Alamar blue and apoptosis assays were used to measure the respective proliferation and apoptosis rates.Cyclooxygenase-2(COX-2)expression was determined by realtime RT-PCR and Western blot assays after miR-143transfection.Reporter plasmids were constructed,and a luciferase reporter assay was used to identify the miR-143 binding site on COX-2.RESULTS:Both miR-143-5p and miR-143-3p were significantly downregulated in multiple gastric cancer cell lines.Forced miR-143-5p and miR-143-3p expression in gastric cancer cells produced a profound cytotoxic effect.MiR-145-5p transfection into gastric cancer cells resulted in a greater growth inhibitory effect(61.23%±3.16%vs 46.58%±4.28%,P<0.05 in the MKN-1cell line)and a higher apoptosis rate(28.74%±1.93%vs 22.13%±3.31%,P<0.05 in the MKN-1 cell line)than miR-143-3p transfection.Further analysis indicated that COX-2 expression was potently suppressed by miR-143-5p but not by miR-143-3p.The activity of a luciferase reporter construct that contained the 3’-untranslated region(UTR)of COX-2 was downregulated by miR-143-5p(43.6%±4.86%,P<0.01)but not by miR-143-3p.A mutation in the miR-145-5p binding site completely ablated the regulatory effect on luciferase activity,which suggests that there is a direct miR-145-5p binding site in the 3’-UTR of COX-2.CONCLUSION:Both miR-143-5p and miR-143-3p function as anti-oncomirs in gastric cancer.However,miR-143-5p alone directly targets COX-2,and it exhibits a stronger tumor suppressive effect than miR-143-3p. AIM: To investigate the function of microRNA-143 (miR-143) in gastric cancer and explore the target genes of miR-143. METHODS: A quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis was performed to evaluate miR-143 expression in gastric cancer cell lines. After transfecting gastric cancer cells with miR-143-5p and miR-143-3p precursors, Alamar blue and apoptosis assays were used to measure the respective proliferation and apoptosis rates. Cyclooxy-genase-2 (COX-2) expression was determined by realtime RT-PCR and Western blot assays after miR-143 transfection. Reporter plasmids were constructed, and a luciferase reporter assay was used to identify the miR-143 binding site on COX-2. RESULTS: Both miR-143-5p and miR-143-3p were significantly downregulated in multiple gastric cancer cell lines. Forced miR-143-5p and miR-143-3p expression in gastric cancer cells produced a profound cytotoxic effect. MiR-145-5p transfection into gastric cancer cells resulted in a greater growth inhibitory effect (61.23% +/- 3.16% vs 46.58% +/- 4.28%, P < 0.05 in the MKN-1 cell line) and a higher apoptosis rate (28.74% +/- 1.93% vs 22.13% +/- 3.31%, P < 0.05 in the MKN-1 cell line) than miR-143-3p transfection. Further analysis indicated that COX-2 expression was potently suppressed by miR-143-5p but not by miR-143-3p. The activity of a luciferase reporter construct that contained the 3'-untranslated region (UTR) of COX-2 was downregulated by miR-143-5p (43.6% +/- 4.86%, P < 0.01) but not by miR-143-3p. A mutation in the miR-145-5p binding site completely ablated the regulatory effect on luciferase activity, which suggests that there is a direct miR-145-5p binding site in the 3'-UTR of COX-2. CONCLUSION: Both miR-143-5p and miR-143-3p function as anti-oncomirs in gastric cancer. However, miR-143-5p alone directly targets COX-2, and it exhibits a stronger tumor suppressive effect than miR-143-3p. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第43期7758-7765,共8页 世界胃肠病学杂志(英文版)
关键词 GASTRIC cancer MicroRNA-143 Anti-oncomir CYCLOOXYGENASE-2 APOPTOSIS Gastric cancer MicroRNA-143 Anti-oncomir Cyclooxygenase-2 Apoptosis
  • 相关文献

参考文献32

  • 1Bing-Li Wu,Li-Yan Xu,Ze-Peng Du,Lian-Di Liao,Hai-Feng Zhang,Qiao Huang,Guo-Qiang Fang,En-Min Li.MiRNA profile in esophageal squamous cell carcinoma:Downregulation of miR-143 and miR-145[J].World Journal of Gastroenterology,2011,17(1):79-88. 被引量:31
  • 2Maria I. Almeida,Milena S. Nicoloso,Lizhi Zeng,Cristina Ivan,Riccardo Spizzo,Roberta Gafà,Lianchun Xiao,Xinna Zhang,Ivan Vannini,Francesca Fanini,Muller Fabbri,Giovanni Lanza,Rui M. Reis,Patrick A. Zweidler–McKay,George A. Calin.Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells[J]. Gastroenterology . 2012 (4)
  • 3Lipeng Liu,Xiaohua Yu,Xiaofang Guo,Zhi Tian,Min Su,Yu Long,Chunxia Huang,Feng Zhou,Meiling Liu,Xinhua Wu,Xiaochun Wang.miR-143 is downregulated in cervical cancer and promotes apoptosis andinhibits tumor formation by targeting Bcl-2[J]. Molecular Medicine Reports . 2012 (3)
  • 4Bo Zhong,Xiaohan Cai,Snigdha Chennamaneni,Xin Yi,Lili Liu,John J. Pink,Afshin Dowlati,Yan Xu,Aimin Zhou,Bin Su.From COX-2 inhibitor nimesulide to potent anti-cancer agent: Synthesis, in vitro, in vivo and pharmacokinetic evaluation[J]. European Journal of Medicinal Chemistry . 2011
  • 5Xinhua Li,Feijun Luo,Qian Li,Meihua Xu,Deyun Feng,Guiying Zhang,Wei Wu.Identification of new aberrantly expressed miRNAs in intestinal-typegastric cancer and its clinical significance[J]. Oncology Reports . 2011 (6)
  • 6Wen Gao,Yue Yu,Hailong Cao,Hua Shen,Xiaodong Li,Shiyang Pan,Yongqian Shu.Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis[J]. Biomedicine & Pharmacotherapy . 2010 (6)
  • 7William K.K. Wu,Chi H. Cho,Chung W. Lee,Daiming Fan,Kaichun Wu,Jun Yu,Joseph J.Y. Sung.Dysregulation of cellular signaling in gastric cancer[J]. Cancer Letters . 2010 (2)
  • 8Hao Zhang,Xiaobing Cai,Yang Wang,Hao Tang,Daki Tong,Fang Ji.microRNA-143, down-regulated in osteosarcoma, promotes apoptosis andsuppresses tumorigenicity by targeting Bcl-2[J]. Oncology Reports . 2010 (5)
  • 9B. P. L.Wijnhoven,D. J.Hussey,D. I.Watson,A.Tsykin,C. M.Smith,M. Z.Michael.MicroRNA profiling of Barrett’s oesophagus and oesophageal adenocarcinoma[J]. Br J Surg . 2010 (6)
  • 10Fernando Colbari Amaral,Natalia Torres,Fabiano Saggioro,Luciano Neder,Hélio Rubens Machado,Wilson Araújo Silva,Ayrton Custódio Moreira,Margaret Castro.MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors[J]. The Journal of Clinical Endocrinology & Metabolism . 2009 (1)

二级参考文献29

  • 1Roush SF, Slack FJ. Micromanagement: a role for microRNAs in mRNA stability. ACS Chem Biol 2006; 1:132-134.
  • 2Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Mallet B, Hayward DC, Ball EE, Degnan B, MOiler P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408:86-89.
  • 3Rajewsky N. microRNA target predictions in animals. Nat Genet 2006; 38 Suppl: S8-S13.
  • 4Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94:776-780.
  • 5Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101:2999-3004.
  • 6Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
  • 7Tricoli JV, Jacobson JW. MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis. Cancer Res 2007; 67: 4553-4555.
  • 8Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83:18-29.
  • 9Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349:2241-2252.
  • 10Kan T, Meltzer SJ. MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 2009; 9: 727-732.

共引文献30

同被引文献53

引证文献15

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部